Dorsey & Whitney Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
3,500
-20
-0.6% -$6.57K 0.06% 284
2025
Q4
$1.23M Buy
3,520
+253
+8% +$85.5K 0.07% 237
2025
Q3
$1.06M Sell
3,267
-221
-6% -$68.7K 0.06% 271
2025
Q2
$1.36M Sell
3,488
-102
-3% -$41K 0.07% 219
2025
Q1
$1.56M Buy
3,590
+209
+6% +$83.9K 0.09% 198
2024
Q4
$1.25M Sell
3,381
-154
-4% -$64.4K 0.07% 223
2024
Q3
$1.84M Buy
3,535
+149
+4% +$79.6K 0.1% 170
2024
Q2
$1.83M Buy
3,386
+18
+0.5% +$9.51K 0.13% 141
2024
Q1
$1.75M Sell
3,368
-87
-3% -$43.3K 0.12% 150
2023
Q4
$1.63M Sell
3,455
-436
-11% -$202K 0.13% 155
2023
Q3
$1.69M Sell
3,891
-84
-2% -$38.1K 0.15% 132
2023
Q2
$1.77M Buy
3,975
+68
+2% +$31.4K 0.15% 137
2023
Q1
$1.8M Sell
3,907
-67
-2% -$31.9K 0.16% 132
2022
Q4
$2.04M Buy
3,974
+164
+4% +$83.3K 0.2% 114
2022
Q3
$1.73M Sell
3,810
-89
-2% -$42.6K 0.18% 128
2022
Q2
$1.88M Buy
3,899
+37
+1% +$18.3K 0.19% 116
2022
Q1
$1.9M Buy
3,862
+104
+3% +$47.5K 0.17% 126
2021
Q4
$1.74M Buy
3,758
+724
+24% +$305K 0.15% 141
2021
Q3
$1.13M Sell
3,034
-87
-3% -$33.1K 0.1% 175
2021
Q2
$1.19M Buy
3,121
+91
+3% +$34.8K 0.11% 170
2021
Q1
$1.09M Sell
3,030
-3
-0.1% -$965 0.11% 184
2020
Q4
$973K Sell
3,033
-2
-0.1% -$614 0.11% 163
2020
Q3
$814K Sell
3,035
-119
-4% -$32K 0.11% 169
2020
Q2
$830K Buy
3,154
+41
+1% +$10.9K 0.12% 161
2020
Q1
$706K Buy
3,113
+150
+5% +$40.9K 0.12% 158
2019
Q4
$895K Buy
2,963
+559
+23% +$154K 0.12% 155
2019
Q3
$577K Buy
2,404
+183
+8% +$50.1K 0.09% 194
2019
Q2
$627K Buy
2,221
+133
+6% +$36.3K 0.1% 176
2019
Q1
$600K Sell
2,088
-160
-7% -$46.3K 0.09% 176
2018
Q4
$591K Hold
2,248
0.1% 161
2018
Q3
$616K Buy
2,248
+21
+0.9% +$5.45K 0.1% 171
2018
Q2
$530K Buy
2,227
+187
+9% +$43.3K 0.09% 176
2018
Q1
$449K Sell
2,040
-75
-4% -$17.6K 0.08% 183
2017
Q4
$476K Buy
2,115
+340
+19% +$72.4K 0.09% 167
2017
Q3
$337K Buy
1,775
+563
+46% +$107K 0.07% 205
2017
Q2
$229K Sell
1,212
-425
-26% -$76.4K 0.05% 280
2017
Q1
$270K Buy
+1,637
New +$260K 0.05% 246
2015
Q3
Sell
-1,439
Closed -$236K 257
2015
Q2
$236K Buy
+1,439
New +$230K 0.06% 209
2015
Q1
Sell
-1,712
Closed -$214K 266
2014
Q4
$214K Buy
+1,712
New +$212K 0.06% 235

Other funds holding ELV

Dorsey & Whitney Trust's ELV Position: Q1 2026 in Review

Dorsey & Whitney Trust reduced its Elevance Health (ELV) stake by 0.57% in Q1 2026, selling an estimated $6.57K and leaving 3,500 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #284.

Dorsey & Whitney Trust first reported a position in ELV in Q4 2014 and has held it in 39 quarters since. The position peaked at $2.04M in Q4 2022. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Dorsey & Whitney Trust held 3,500 shares of Elevance Health worth $1.02M as of Q1 2026.
  • Dorsey & Whitney Trust sold 20 Elevance Health shares in Q1 2026, an estimated $6.57K.
  • Elevance Health made up 0.06% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #284 holding.
  • Dorsey & Whitney Trust first reported a position in Elevance Health in Q4 2014 and has held it in 39 quarters since.
  • Dorsey & Whitney Trust's Elevance Health position peaked at $2.04M in Q4 2022.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.